ONCOSCREEN’s Post

The Prostate Cancer Foundation's recent guidelines advocate for early prostate-specific antigen (PSA) screening for Black men starting at age 40, addressing the stark disparities in prostate cancer incidence and mortality rates. Led by Dr. Isla Garraway, this initiative emphasizes the need for informed, shared decision-making between patients and healthcare providers, aiming to balance early detection with the risks of overdiagnosis. These tailored recommendations represent a significant step towards reducing health inequities and improving outcomes for a high-risk population, highlighting the importance of awareness and proactive screening strategies. Read here: https://hubs.ly/Q02mdpmD0 #ProstateCancerAwareness

🔬 On 𝐖𝐨𝐫𝐥𝐝 𝐂𝐚𝐧𝐜𝐞𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐃𝐚𝐲, we highlight the critical importance of research in transforming the future of cancer care. ⚗The 𝐄𝐋𝐌𝐔𝐌𝐘 project is focused on tackling #multiplemyeloma, a rare but aggressive blood cancer. With groundbreaking #research, we aim to develop more targeted treatments and improve the quality of life for patients affected by this disease. 🌍 By fostering #collaboration across Europe’s top research institutions and medical experts, we’re accelerating progress toward innovative solutions. Every discovery brings us one step closer to better treatment outcomes. 💡 Research is key to making this vision a reality. #MissionCancer #HorizonEU #WorldCancerResearchDay #MultipleMyeloma #EUfunded #CancerResearch 

The Fiscal Year 2025 (FY25) budget is shaping up to be a tough environment for program funding, but Komen’s Center for Public Policy is calling on lawmakers to prioritize essential breast cancer research and public health programs. Robust funding is necessary to ensure investment in vital biomedical research and cancer screening safety net programs. Legislators need to hear from YOU that funding breast cancer research, screening, diagnosis, and treatment programs is critical. Congress must invest in breast cancer programs at the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH) and Departments of Defense (DOD) to ensure the progress in reducing deaths from breast cancer continues. Urge your lawmakers to preserve funding for these life-saving programs in FY25! https://p2a.co/oKmciK0

Get insights on Ovarian Cancer Research Alliance’s efforts to provide a coverage pathway for Multi-Cancer Early Detection tests, plus learn more about the actions of our Advocate Leaders to tackle pressing issues such as cost of care and health disparities: bit.ly/3wc269d. #TealAction #HealthPolicy #OvarianCancer

🏥 One of the main objectives of the ONCOSCREEN project is to ensure that new technologies and methods of colorectal cancer screening are integrated into public health systems and are made available to all.   🧪 Widespread adoption of these methods can save lives by detecting bowel cancer at earlier stages, when it is most treatable.   🌍 With more accessible screening methods we can reduce health disparities, ensuring that people from all backgrounds can benefit from early and accurate diagnoses!   The future of colorectal cancer screening is promising with the ONCOSCREEN project. Together, we can improve health outcomes and save lives. 💙   #ONCOSCREEN #ColorectalCancer #PublicHealth #EUCRC #EUFunded #CRC #Screening #Innovation #EarlyDiagnosis

🏥 One of the main objectives of the ONCOSCREEN project is to ensure that new technologies and methods of colorectal cancer screening are integrated into public health systems and are made available to all.   🧪 Widespread adoption of these methods can save lives by detecting bowel cancer at earlier stages, when it is most treatable.   🌍 With more accessible screening methods we can reduce health disparities, ensuring that people from all backgrounds can benefit from early and accurate diagnoses!   The future of colorectal cancer screening is promising with the ONCOSCREEN project. Together, we can improve health outcomes and save lives. 💙   #ONCOSCREEN #ColorectalCancer #PublicHealth #EUCRC #EUFunded #CRC #Screening #Innovation #EarlyDiagnosis

🌐 Last week, we held our first plenary meeting in Paris. Symbolically, the meeting took place just before #WorldCancerDay🎗. Gathering more than 58 medical and technology experts, end-users and policymakers across Europe, we have confirmed our determination to develop innovative colorectal cancer #screening technologies for #prevention and #earlydetection. 🤝 By joining efforts with six #EU-funded projects, DIOPTRA Project, LUCIA EU Project, MammoScreen Project, ThermoBreast, PANCAID, and SANGUINE Project, we aim to bring concrete solutions for cancer prevention and early detection, improve understanding of cancer and, ultimately, save lives! #HorizonEurope #EUCancerPlan #MissionCancer #CancerScreening #CancerResearch #EU4Health #HealthUnion #CancerAwareness #CRCScreening #EuropeanCommission

World Cancer Day on 4 February is a reminder of the impact the ALLG has on people’s lives. This year's theme, closing the care gap, aligns with our mission of better treatments, better lives. We are proactive in closing the gap and increasing equitable access to treatment through the work of our Rural and Regional Working Group & the introduction of initiatives such as teletrials. The ALLG is committed to overcoming barriers to enable all patients to access clinical trials regardless of their geographical location. Visit www.allg.org.au for more information. #ALLG #ALLGtrials #bettertreatmentsbetterlives #clinicaltrials   #bloodcancer #bloodcancerawareness #bloodcancercure #bloodcancers #haematology #haematologyresearch #leukaemiaandlymphoma #myeloma #myelomaawareness

🚨 Lack of Diversity in Cancer Clinical Trials 🚨 According to a recent study, cancer clinical trials are becoming less diverse despite national efforts. Patients from underrepresented groups face barriers to accessing potentially life-saving treatments. This needs to change. At Kitsa, we’re committed to creating opportunities for all communities to access clinical trials. Our AI-powered platform makes it easier for community physicians, rural hospitals, and underrepresented groups to participate in research that could revolutionize cancer care. Together, we can build a more inclusive future for clinical trials! 💪 👉 Learn more about how Kitsa helps increase diversity in clinical research: https://kitsa.ai #ClinicalTrials #CancerResearch #HealthEquity #DiversityInTrials #KitsaSolutions #HealthCareInnovation #PatientAccess

🏥 One of the main objectives of the ONCOSCREEN project is to ensure that new technologies and methods of colorectal cancer screening are integrated into public health systems and are made available to all. 🧪 Widespread adoption of these methods can save lives by detecting bowel cancer at earlier stages, when it is most treatable. 🌍 With more accessible screening methods we can reduce health disparities, ensuring that people from all backgrounds can benefit from early and accurate diagnoses! The future of colorectal cancer screening is promising with the ONCOSCREEN project. Together, we can improve health outcomes and save lives. 💙 #ONCOSCREEN #ColorectalCancer #PublicHealth #EUCRC #EUFunded #CRC #Screening #Innovation #EarlyDiagnosis